Ignite II

Carolina Seminar Series | Empowering Trust: Insights from Community Engagement Initiatives
2023-11-08 16:00 - 17:15 (America/New_York) | Virtual
Empowering Trust: Insights from Community Engagement Initiatives
Wednesday, November 8 | 4 p.m. ET | Online
Speaker: Mya Roberson, MSPH, PhD,
Assistant Professor, Department of Health Policy and Management, UNC-Chapel Hill
Community engagement continues to be a critical component in genomic medicine and precision health research where the overall goal is to improve health outcomes of communities. The translation of findings into practice and implementation depends heavily on stakeholder engagement throughout the research process. This seminar session will explore insights gained from various engagement strategies and how appropriate incorporation of community stakeholders’ insights can improve the relevance and usefulness of genomic medicine and precision health research. Speakers and panelists will share their perspectives on community engagement, discuss strategies to address the gaps that remain and how to address the challenge of hesitancy among some communities.
To learn more and register, visit the UNC events page.
Please note: Registration is required for this seminar.

Transdisciplinary Conference for Future Leaders in Precision Public Health
2023-11-09 10:00 - 17:30 | Virtual
Transdisciplinary Conference for Future Leaders in Precision Public Health
Thursday, November 9 | 10 a.m. ET | Online
The UNC Eshelman School of Pharmacy’s Precision Public Health Network is sponsoring this free, virtual conference with expert speakers, a breakout networking session, and a virtual poster session. A follow-up workshop will be held on Thursday, November 16, from 3-6 p.m. ET to discuss priority-setting for the field.
For more information and to register, visit the event page.
Please note: Registration is required.

Precision Medicine and Immunotherapy: The new frontiers in cancer care?
2023-11-10 11:00 - 12:00 | Virtual
Precision Medicine and Immunotherapy: The new frontiers in cancer care?
Friday, November 10 | 11 a.m. ET | Online
Speaker: Ugwuji Maduekwe, MD, MMSc, MPH
Dr. Maduekwe will present an exploration of the dispersion of new therapies in the care of cancer that are inequitably distributed and solutions to closing these gaps.
To learn more and register, visit the webinar page.
Please note: Registration for the full webinar series is required.

NASEM | Roundtable on Genomics and Precision Health - Strategic Plan Reflection on the Roundtable's Work Since 2020
2023-11-15 12:00 - 13:15 | Virtual
Roundtable on Genomics and Precision Health – Strategic Plan Reflection on the Roundtable’s Work Since 2020
Wednesday, November 15 | 12 p.m. ET | Online
The Roundtable on Genomics and Precision Health will host a virtual event to highlight the work of the Roundtable since the adoption of its strategic plan in 2020. Speakers will provide their perspectives on the goals and key takeaways heard from workshop and event speakers as well as look ahead to what comes next. Public events include:

Improving Diversity of the Genomics Workforce: A Workshop (2021)
Views & Voices: Reporting Genetics and Genomics (2022)
Realizing the Potential of Genomics across the Continuum of Precision Health Care: A Workshop (2022)
Next-Generation Screening – The Promise and Perils of DNA Sequencing of Newborns at Birth: A Workshop (2023)

The event will be accessible via webinar. Learn more and register on the event page.

Rapid Genome Sequencing for Diagnosing Critically Ill Infants and Children: From Evidence to Equitable Implementation
2023-11-30 12:00 - 13:00 | Virtual
Rapid Genome Sequencing for Diagnosing Critically Ill Infants and Children: From Evidence to Equitable Implementation
Thursday, November 30 | 12-1 p.m. ET | Online
Speakers: Dr. Stephen F. Kingsmore, president/CEO of Rady Children’s Institute for Genomic Medicine (RCIGM)
To learn more and register, visit the CDC event page.
Please note: Registration is required for this webinar.

Carolina Seminar Series | Precision Medicine Research and Novel Clinical Offerings: Ensuring Equitable Impact Through Implementation Science
2023-12-06 16:00 - 17:15 | Virtual
Precision Medicine Research and Novel Clinical Offerings: Ensuring Equitable Impact Through Implementation Science
Wednesday, December 6 | 4 p.m. ET | Online
Speakers: Caitlin Allen, PhD, MPH
Assistant Professor, Medical University of South Carolina
Elizabeth Mayer-Davis, PhD, RD
Boshamer Distinguished Professor of Nutrition and Medicine, UNC-Chapel Hill
As technologies and health interventions expand at a rapid rate in healthcare, many providers and patients desire quick and efficient incorporation of these new offerings in to practice. The field of implementation science can be critical in studying the barriers and facilitators to bring options previously available only in the research realm to the clinic. The design and development of health interventions are increasingly informed by implementation science theories, models, and frameworks to emphasize diverse reach and improve adoption and increase health equity in under served and marginalized communities. By testing new clinical offerings with implementation science methodologies, we can improve the quality of health practices for all patients while promoting equity and inclusion and ensuring that the availability of novel clinical offerings does not exacerbate existing health disparities.
To learn more and register, visit the UNC events page.
Please note: Registration is required for this seminar.

NHGRI Division of Intramural Research Seminar
2023-12-14 14:00 - 15:00 | Virtual
Thursday, December 14 | 2 – 3 p.m. | Bethesda, MD & Online
The Division of Intramural Research (DIR) sponsors a monthly series of talks by intramural and special guest speakers celebrating genetics and genomics research. Speakers are selected by NHGRI intramural faculty and trainees and cover research topics of interest to a wide audience.
All seminars are free and open to the public. Seminar titles and other details are updated on the NHGRI website as information becomes available.
Speaker:
Marius Wernig, M.D., Ph.D.
Professor in the Departments of Pathology and Chemical and Systems Biology
Stanford University School of Medicine
Hosts: William Gahl, May Christine Malicdan and Marie Morimoto

View past presentations, learn more about upcoming seminars, and register to attend on the NHGRI website.

Personalized Risk Assessment for Early Detection of Cancer
2023-12-21 09:00 - 10:00 | Virtual
Personalized Risk Assessment for Early Detection of Cancer
Thursday, December 21 | 9 a.m. ET | Online
Speaker: Dr. Nora Pashayan
Dr. Pashayan is a Professor of the Epidemiology of Aging and honorary Consultant in Public Health Medicine at the University of Cambridge. She is a cancer epidemiologist, a clinician with specialties in both Family Medicine and Public Health Medicine, and the Director of Training for the International Alliance for Cancer Early Detection. Dr. Pashayan’s primary research field is cancer early detection, risk stratification, and population-level screening. Her research focuses on understanding disease courses, evaluating screening strategies, and implementation of novel screening strategies.
This talk will introduce the concept of risk-stratified cancer screening and explore the essential considerations for implementation of such a screening program. Examples on integration and implementation will be drawn from the ongoing Canadian study, PERSPECTIVE I&I.
To learn more and register, visit the GGMC Educational Webinar Series page.
Please note: Registration is required for this webinar.

An Overview of Applied Machine Learning in Medicine at UNC
2024-01-04 12:00 - 13:00 | Virtual
An Overview of Applied Machine Learning in Medicine at UNC
Thursday, January 4 | 12-1 p.m. ET | 4th Floor Old Clinic Auditorium or Online
Speaker: Amanda Nelson, MD
Associate Professor of Medicine, UNC-Chapel Hill
A discussion on the application of AI tools to answer clinical questions around diagnosis, phenotyping, prognosis, and precision medicine using examples from investigators at UNC.

WebEx Information:
https://uncsom.webex.com/uncsom/j.php?MTID=m893f54367d9d2ac90bbac612e815bf88
Meeting number (access code): 2314 463 7243
Meeting password: [REDACTED]

Global Diversity, Local Context: The Role of Ancestry, Genetics, and Environment on Human Health
2024-01-11 15:00 - 16:00 | Virtual
Global Diversity, Local Context: The Role of Ancestry, Genetics, and Environment on Human Health
Thursday, January 11 | 3-4 p.m. ET | In-person & Virtual
Speaker: Genevieve Wojcik, PhD, MHS
Genetic Epidemiologist and Assistant Professor of Epidemiology
Johns Hopkins Bloomberg School of Public Health
Dr. Wojcik’s research focuses on understanding the role of ancestry in genetic risk and developing solutions to address health inequities for diverse and admixed populations, as well as genetic susceptibility to infectious disease. Her most recent work explores the interaction of genetic ancestry and environment in admixed populations and downstream consequences for genetic risk prediction. Dr. Wojcik is a member of multiple NIH consortia, including the Population Architecture using Genomics and Epidemiology (PAGE) Study, the Clinical Genome Resource (ClinGen), and the Polygenic Risk Methods in Diverse Populations (PRIMED) Consortium.
The Genomics and Health Disparities Lecture Series was formed to enhance opportunities for dialogue about how innovations in genomics research and technology can impact health disparities. Topics will range from basic science to translational research.
To learn more and register, visit the lecture series page.
Please note: Zoom registration is required for virtual attendees.

Duke Genomic Seminar Series
2024-02-08 14:00 - 15:00 | Duke Neurobiology Research Center, 311 Research Drive, Durham, NC, 27710, United States
A platform approach to develop and deploy CRISPR-Cas based experimental therapies for inborn errors of immunity in an academic/nonprofit setting
Thursday, February 8 | 2-3 p.m. ET | Bryan Neurobiology Research Building, Rm 103
Speaker: Fyodor Urnov, PhD
Professor of Molecular & Cellular Biology, University of California, Berkeley
Director of Technology & Translation, Innovative Genomics Institute
The vast majority of diseases clinically tractable by genome editing using current-state technology are not the targets of active preclinical or clinical development. Addressing this issue will require more involvement of the academic/nonprofit sector, but despite an existing charted path for advancing genome editing of specific cell types and tissues (such as T cells, hematopoietic stem cells, the liver, and the retina) to the clinic, there presently is only one open US IND for genome editing by an all-academic group. A key reason is that the current manufacturing, regulatory, and healthcare economics environment is not configured to maximize clinical impact of a technology like CRISPR-Cas. Under the framework that exists today, a pediatric patient newly diagnosed with a terminal illness such as a severe inborn error of immunity due to a never-before-seen but clinically editable mutation and a life expectancy of < 1 yr will have to wait ~3.5 years until a gene editing medicine is engineered, tested, and manufactured at an approximate total cost of $9m. An actionable path through this status quo is to develop and clinically derisk a dedicated nonclinical development path for use in academic/nonprofit settings in N=1/rare situations of dire medical need. From a technology standpoint, this will require comprehensive leveraging of the intrinsically platform nature of CRISPR-Cas gene editing. The Innovative Genomics Institute in close partnership with clinicians at UCSF and UCLA is developing such a platform focused on inborn errors of immunity, where ca 112,000 known patients suffering from 505 currently known diseases lack even a single open trial for genome editing open at the present time.
To learn more, visit Duke’s Genomic Seminar Series page.
Please note: This seminar series occurs quarterly with some events occurring virtually only and others in-person with streaming options.

Personalized Therapeutics: Clinical Reality and Future Challenges
2024-02-15 09:00 - 10:00 | Virtual
Personalized Therapeutics: Clinical Reality and Future Challenges
Thursday, February 15 | 9 a.m. ET | Virtual
Speaker: George P. Patrinos
Dr. Patrinos is a professor of pharmacogenomics and pharmaceutical biotechnology in the University of Patras’ (Greece) Department of Pharmacy, and holds adjunct professorships at Erasmus MC, Faculty of Medicine, Rotterdam (the Netherlands) and the United Arab Emirates University, College of Medicine, Department of Genetics and Genomics, Al-Ain (UAE). He also served for 12.5 years as full member and Greece’s National Representative in the CHMP Pharmacogenomics Working Party of the European Medicines Agency (EMA) and as Chair of the Global Genomic Medicine Collaborative (G2MC) since 2018.
About the Talk: This talk will provide a summary of the PREPARE and Em-HEART clinical studies in psychiatry and cardiology, and ethical and regulatory challenges in the field of pharmacogenomics.
To learn more and register, visit the GGMC Educational Webinar Series webpage.
Please note: Registration is required.

Population Screening for Hereditary Hemochromatosis More than a Quarter Century After Gene Discovery – Current Status and the Path Forward
2024-02-15 13:00 - 14:00 | Virtual
Population Screening for Hereditary Hemochromatosis More than a Quarter Century After Gene Discovery –
Current Status and the Path Forward
Thursday, February 15 | 1-2 p.m. ET | Virtual
Speakers: Paul C. Adams, MD, Professor, Division of Gastroenterology, Western University
Gail P. Jarvik, MD, PhD, Head and Professor, Division of Medical Genetics, University of Washington
Kris V. Kowdley, MD, FACP, FACG, AGAF, FAASLD, Director, Liver Institute Northwest
In this webinar, speakers will discuss how knowledge about hereditary hemochromatosis (HH) has evolved since the discovery of the HFE gene in 1997, current opportunities for clinical and public health action to prevent disease, and future research priorities to advance case detection and reduce clinical complications from HH.
To learn more and register, visit the CDC events page.
Please note: Registration is required for this webinar.

Immune (check point) Related Adverse Events
2024-02-28 12:00 - 13:00 | Virtual
Immune (check point) Related Adverse Events
Wednesday, February 28 | 12 p.m. ET | Online
Speaker: Frances Collichio, MD, Professor of Medicine, UNC Chapel Hill
Dr. Collichio will review the common and uncommon side effects of immune check point inhibitors. She will also discuss the relatively new concept of delayed immune related events.
To learn more and register, visit the event webpage.
Please note: Registration is required for this webinar.

Translating Science from Bench to Bedside: A Case for Extracellular Vesicles
2024-02-29 09:00 - 10:00 | Virtual
Translating Science from Bench to Bedside: A Case for Extracellular Vesicles
Thursday, February 29 | 9 a.m. ET | Online
Speaker: Dr. Carlos Salomon Gallo
Dr. Salomon is the head of the Translational Extracellular Vesicles in Obstetrics and Gynae-Oncology Group, NHMRC Investigator Fellow and is considered a worldwide authority on extracellular vesicles (EVs) biomarkers for complications of pregnancies and ovarian cancer (OC). In the last 10 years, Dr. Salomon’s primary research and commercialization activities have focused on the identification and validation of biomarkers, and development of In Vitro Multivariate Index Assays for clinically relevant complications (including ovarian cancers, and obstetrical syndromes) and their translation into clinical applications. He is a pioneer in investigating the release of EVs by the placenta and tumor cells and their utility as a biomarker for a wide range of pregnancy complications and OC.
This talk will cover the burgeoning field of EVs signaling holds the potential to revolutionize our understanding of cancer biology and offers new avenues for non-invasive diagnostics and therapeutic interventions. EVs have been implicated in various aspects of cancer progression, including tumor initiation, metastasis, and response to therapy. From the early stages of tumor development, tumor-derived EVs are detectable in the circulation.
To learn more and register, visit the GGMC Educational Webinar Series webpage.
Please note: Registration is required for this webinar.

2024 ACMG Annual Clinical Genetics Meeting
2024-03-12 - 2024-03-16 | Metro Toronto Convention Center, 255 Front St W, Toronto, Ontario, M5V 2W6, Canada
2024 ACMG Annual Clinical Genetics Meeting
March 12-16 | Toronto, Canada
The ACMG sponsors an Annual Clinical Genetics Meeting and other events offering educational content in clinical genetics with the purpose of serving its members, other healthcare professionals and the public. Experience the transformation of medical genetics as treatments can increasingly be tailored with precision medicine and therapeutics.
To learn more and register, visit the meeting website.
Please note: Registration is required for in-person attendance and does not include session recordings. ACMG’s Digital Edition for recordings can be purchased separately and will be made available after the conference.

Ethical Aspects of AI in Biomedical Research: The NIH Bridge to AI Initiative
2024-03-22 12:00 - 13:00 | Virtual
Ethical Aspects of AI in Biomedical Research: The NIH Bridge to AI Initiative
Friday, March 22 | 12 p.m. ET | Hybrid: 321 MacNider Hall & Virtual
Speaker: Vardit Ravitsky, PhD
President and CEO, The Hastings Center
Senior Lecturer on Global Health and Social Medicine, Harvard Medical School
Professor, University of Montréal
Dr. Ravitsky will be speaking at the UNC Center for Bioethics’ Research Ethics Grand Rounds Merrimon Lecture. She is the President and CEO of The Hastings Center, an independent, nonpartisan bioethics research institute that is among the most prestigious bioethics and health policy institutes in the world. Dr. Ravitsky joins the Center from the University of Montreal where she was Professor at the Bioethics Program, School of Public Health. She is also a Senior Lecturer on Global Health and Social Medicine at Harvard Medical School. She received her PhD from Bar-Ilan University in Israel, her MA from the University of New Mexico, and her BA from the Sorbonne University in Paris, France. Dr. Ravitsky runs an active research program and holds several positions on advisory boards. Her research in bioethics focuses on ethical, legal, and social implications of genomics and assisted reproductive technologies, with an emphasis on emerging biotechnologies and their implications for women’s autonomy and for disability rights. She also studies the ethics of AI in biomedicine.
To learn more, visit the event webpage.
Zoom Webinar Link | Passcode: [REDACTED]

2024 Precision Medicine Tri-Conference
2024-03-26 - 2024-03-28 | Hilton San Diego Bayfront, 1 Park Boulevard, San Diego, CA, 92101, United States
2024 Precision Medicine Tri-Conference
March 26-28 | San Diego, CA
Join thousands of international thought leaders to discuss the latest research, technologies, innovation and business models in precision medicine and precision health. Topics will include innovation and market access strategies for at-home diagnostics, liquid biopsy and advanced diagnostics for precision oncology, AI and digital tools, spatial biology and single-cell multiomics in advancing precision medicine and more.
To learn more and register, visit the conference website.
Please note: Registration is required for both in-person and virtual attendees.

Carolina Seminar Series | Ensuring Fairness: At the Crossroads of Equity and Economic Considerations in Precision Medicine
2024-03-26 12:00 - 13:00 | Virtual
Ensuring Fairness: At the Crossroads of Equity and Economic Considerations in Precision Medicine
Tuesday, March 26 | 12 p.m. ET | Virtual
Speaker: Kate Saylor, PhD
Fellow, Ethical, Legal, and Social Implications (ELSI) of Genetics and Genomics,
Perelman School of Medicine at the University of Pennsylvania
Efforts to expand access to genomic health and precision medicine have resulted in a proliferation of screening programs for healthy adult populations across the nation. Issues of fairness and equity abound in medicine and are a critical component of assessing implementation of these genomic health and precision medicine efforts. But how can programs such as genomic screening ensure equitable access within a healthcare system that is already characterized by massive health disparities and barriers to equitable access? When and how should cost-effectiveness be considered when designing screening programs and their offerings? How can cost-effectiveness models incorporate justice, equity and inclusion? In this seminar session, we will explore these questions and the overall relationship between equity and economic considerations in precision medicine.
To learn more and register, visit the event webpage.

The All of Us Research Program
2024-03-28 09:00 - 10:00 | Virtual
The All of Us Research Program
Thursday, March 28 | 9 a.m. ET | Online
Speaker: Geoffrey Ginsburg, MD, PhD
Dr. Geoffrey Ginsburg is the chief medical and scientific officer of the National Institute of Health (NIH)’s All of Us Research Program, where he leads the scientific vision and strategy for the program. Previously, he was founding director of the Center for Applied Genomics & Precision Medicine at Duke University School of Medicine and held senior leadership roles at Millennium Pharmaceuticals Inc. He has influenced precision medicine in the U.S. and internationally, serving as co-chair of the National Academies’ Roundtable on Genomic and Precision Health, a founding co-chair of the International HundredK+ Cohorts Consortium, and founder and president of the Global Genomic Medicine Collaborative (G2MC).
This talk will cover the All of Us Research Program—a historic effort to gather data from 1 million or more people in the U.S. to accelerate research and improve health, with a focus on engaging communities historically underrepresented in biomedical research. Since national launch in 2018, less than 750,000 participants have enrolled. Diverse participant partners (about 80% from underrepresented backgrounds including racial/ethnic minority groups, gender minority groups, disability status, access to healthcare, etc.) are sharing health-related data and biospecimens. All of Us data are housed in the cloud-based Researcher Workbench, which includes tools, support resources, sample data workbooks and more.
To learn more and register, visit the GGMC Educational Webinar Series webpage.
Please note: Registration is required for this webinar.

All of Us Researchers Convention
2024-04-03 - 2024-04-04 | Virtual
All of Us Researchers Convention
April 3-4 | Virtual
This free, virtual event is open to researchers across all disciplines and career stages. It provides an opportunity for researchers who use All of Us data to showcase their work for others who share their interests in precision medicine. Abstract submissions can be on any topic. Both in-progress and previously published research projects are eligible for submission. Submit an abstract by January 19, 2024 at 11:59 p.m. ET.
For more information about the convention and updates on when registration opens, visit the event website.
Please note: Registration is required for this event.

NCSU Data Science and Environmental Health Science Research Symposium
2024-04-05 08:30 - 17:00 | NCSU Hunt Library, 1070 Partners Way, Raleigh, NC, 27606, United States
Data Science and Environmental Health Science Research Symposium
Friday, April 5 | 8:30 a.m. ET | NC State Hunt Library
This interdisciplinary forum will present the research activities in population genomics, genomic-driven new approach methodologies and environmental health disparities and address approaches to handling big data.
For more information and to register, visit the symposium webpage.

Working Towards Justice & Genetic Health Literacy in Clinical Genomics
2024-05-22 11:00 - 12:30 | Virtual
Working Towards Justice & Genetic Health Literacy in Clinical Genomics
Wednesday, May 22 | 11 a.m. ET | Virtual
Speakers:
Dr. Janeth Sanchez, PhD, MPH
Program Director for Health Equity at National Institutes of Health
Dr. Janina Jeff, PhD, MS
Bioinformatics Scientist at Illumina and Host of In Those Genes Podcast
Join the UNC Program for Precision Medicine in Health Care (PPMH) for a seminar and panel about working towards justice and genetic health literacy in clinical genomics and the complexity of supporting informed decision making by members of vulnerable or marginalized groups.
To learn more and register, visit the event page. Please note: Registration is required for this seminar.

Integrating Genetics into the Tanzanian Healthcare: An Overview
2024-05-28 09:00 - 10:00 | Virtual
Integrating Genetics into the Tanzanian Healthcare: An Overview
Tuesday, May 28 | 9 a.m. ET | Virtual
Speaker: Dr. Mohamed Zahir Alimohamed
Dr. Alimohamed will provide an overview of the current landscape and future prospects of integrating genetics into healthcare practices in Tanzania, beginning by outlining the existing healthcare infrastructure and genetic services available in the country. Next, Dr. Alimohamed will discuss the challenges and opportunities faced in implementing genetic testing, counseling, and treatment options within the Tanzanian healthcare system.
To learn more and register, visit the GGMC Educational Webinar Series webpage.
Please note: Registration is required for this webinar.

Biomedicine in the Age of Generative AI
2024-06-11 12:00 - 13:00 | Virtual
Biomedicine in the Age of Generative AI
Tuesday, June 11 | 12 p.m. ET | Virtual
Speaker: James Zou, PhD
Associate Professor, Biomedical Data Science, Computer Science, and Electrical Engineering
Stanford University
This talk will explore how to develop and use generative artificial intelligence (AI) to help researchers, clinicians, and patients. Dr. Zou will discuss how to use AI to generate recipes for making and validating new drugs and how visual-language AI can help clinicians interpret histology images. Finally, he will discuss using large language models (LLM) to simplify medical forms and improve informed consent for patients as well as share perspectives on what’s on the new horizon for generative AI.
Zoom Information
Join via PC, Mac, iOS or Android: https://zoom.us/j/98840587618?pwd=[REDACTED]
Meeting ID: 988 4058 7618
Passcode: [REDACTED]

Value of a Genomic Result in Rare Disease Patients – Sri Lankan Experience
2024-06-27 09:00 - 10:00 | Virtual
Value of a Genomic Result in Rare Disease Patients – Sri Lankan Experience
Thursday, June 27, 2024 | 9 a.m. ET | Virtual
Speaker: Dr. Kawmadi Gunawardena
Dr. Gunawardena will discuss the impact of genomic results in rare disease patients by illustrating interesting case scenarios of Sri Lankan patients.
To learn more and register, visit the GGMC Educational Webinar Series webpage.
Please note: Registration is required for this webinar.

PRECISE-IHCC Conference 2024
2024-08-21 - 2024-08-23 | One Farrer Hotel, 1 Farrer Park Station Rd., 217562, Singapore
PRECISE-IHCC Conference 2024 | From Cohorts to Clinics: The New Landscape of Global Healthcare
August 21 – 23 | Singapore
Jointly organized by Precision Health Research, Singapore (PRECISE) and the International Health Cohorts Consortium (IHCC), this three-day conference will bring together some 600 thought leaders, clinicians, scientists, biotechs, and patient advocacy associations from across the world who are at the forefront of precision medicine and public health innovation.
Themed “From Cohorts to Clinics – The New Landscape of Global Healthcare”, the conference aims to provide a unique platform to spotlight Singapore’s and the international community’s advancements in precision medicine to provide diverse insights and a broad spectrum of experiences and knowledge.
To learn more and register, visit the event page. Please note: Registration is required.

Call for Abstracts
Registrants are also invited to submit abstracts for poster presentations. Registrants who submit abstracts may have a chance to be shortlisted for an oral presentation at the conference. The deadline for abstract submissions has been extended to May 31, 2024 at 11:59 p.m. ET.
Abstracts can be submitted here.

NHGRI Division of Intramural Research Seminar Series
2024-09-05 14:00 - 15:00 | Lipsett Amphitheater, 10 Center Dr., Bethesda, MD, 20814, United States
The importance of environmental and ancestral context in genetic risk examination for diverse and admixed populations
Thursday, September 5 | 2 p.m. ET | Hybrid: In-person and Virtual
Speaker: Genevieve Wojcik, PhD, MHS
Assistant Professor, Johns Hopkins Bloomberg School of Public Health
As a statistical geneticist and genetic epidemiologist, Dr. Wojcik’s research focuses on method development for diverse populations, specifically in admixed populations. Many of her efforts focus on improving statistical methods for complex trait mapping and polygenic risk scores for these populations to address existing health inequities and ensure downstream translation for all.
The second arm of Dr. Wojcik’s research program focuses on the genetic susceptibility to infectious disease and vaccine response, with an eye towards host-pathogen co-evolution.
For more information and to register, visit the seminar series webpage. Please note: Zoom registration is required for virtual attendees.

ASHG 2024 Annual Meeting
2024-11-05 - 2024-11-09 | Colorado Convention Center, 700 14th St, Denver, CO, 80202, United States
ASHG 2024 Annual Meeting
November 5 – 9 | Denver, Colorado
Join the American Society of Human Genetics for their 5-day meeting, which will cover a broad spectrum of topics including new technologies, applications, and research to showcase the most compelling genetics and genomics science of the year.
To learn more and register, visit the ASHG meeting webpage. Please note: Registration is required.

2024 Precision Health Research Symposium
2024-11-14 - 2024-11-15 | Medical University of South Carolina, 171 Ashley Avenue, Charleston, SC, 29425, United States
2024 Precision Health Research Symposium
November 14 – 15 | Medical University of South Carolina
Join the Precision Public Health Network for their third conference focused on Advancing Equity through Precision Health. The conference will coincide with MUSC’s second annual Precision Health Research Symposium.
For more conference information and to register, visit the event page. Please note: Registration is required.

Call for Abstracts
Registrants interested in participating in the symposium poster session are invited to submit abstracts. Abstracts should have a maximum of 300 words and abstract submitters must register for Day 1 of the symposium. Abstract submissions close on June 15, 2024. Abstracts can be submitted here.
